Non categorizzato Moderna down 6.5% after flu shot study disappoints Febbraio 17, 2023 0 commenti Moderna Inc.’s stock dropped 6.5% in premarket trading on Friday after yesterday’s publication of its influenza vaccine trial results failed to impress. The experimental messenger RNA-based … About the author:
Get involved!
Comments